search
Back to results

Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for Treatment of Major Depressive Episode in the Elderly

Primary Purpose

Depression

Status
Unknown status
Phase
Phase 2
Locations
Israel
Study Type
Interventional
Intervention
dTMS treatment (H1 Coil)
Sponsored by
Shalvata Mental Health Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression

Eligibility Criteria

68 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed by a senior psychiatrist as suffering from major depression episode according to DSM-IV (either as a part of a unipolar or a bipolar disorder).
  • Rating on HDRS ≥ 20.
  • Age: 68 years and above
  • Treated for the current depressive episode, at least 6 weeks per antidepressant with one antidepressant in accepted dose, without improvement, and/or intolerance to 2 antidepressants, according to medical chart and ATHF (antidepressant treatment history form) instruction guidelines.
  • Gave informed consent for participation in the study.
  • Negative answers on safety screening questionnaire for TMS.
  • If referred by a treating psychiatrist, he or she approves of the subject's participation in the study.

Exclusion Criteria:

  • Axis 2 diagnosis, which is considered prominent to the current depressive episode.
  • Substantial suicidal risk as judged by the treating psychiatrist or by an independent psychiatrist.
  • Attempted suicide in the past year.
  • Cognitive impermanent - if MMSE < 24, patient will be further assessed , and may be excluded according to the primary investigator's discretion
  • History of seizure.
  • History of epilepsy or seizure in first degree relatives.
  • Any CNS disorder that may increase risk of seizure significantly
  • History of a significant head injury.
  • History of any metal in the head (outside the mouth).
  • Known history of any metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, surgical clips or any medical pumps.
  • History of frequent or severe headaches.
  • Use of hearing aids for hearing loss.
  • Known history of cochlear implants.
  • History of drug abuse or alcoholism.
  • Serious and unstable medical condition, which is likely to exacerbate or endanger the patient during the treatment period.
  • Inadequate communication with the patient.
  • Under custodial care.
  • Participation in current clinical study or clinical study within 30 days prior to this study.
  • Patients suffering from bipolar disorder, not currently treated by mood stabilizers
  • Patients declared as legally incompetent, with an appointed physical guardian and/or cannot sign informed consent due to cognitive incompetence.

Sites / Locations

  • Shalvata Mental Health Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

elderly depressed patients

Arm Description

Twenty seven (27) patients aged 68 years or above, currently suffering from a major depressive episode, who did not respond to treatment with at least one antidepressant medications in the recommended dosage and duration, or could not tolerate at least two antidepressants.

Outcomes

Primary Outcome Measures

Safety of the H1-Coil
maintaining subject's pre treatment, physical and neurological status.
Clinical antidepressant response
a decline in Hamilton depression rating scale (HDRS) from the baseline rating by 50%.

Secondary Outcome Measures

Clinical antidepressant remission
exit Hamilton Depression Rating Scale <9.
Symptomatic improvement at the end point.
Change in Hamilton Anxiety Rating Scale (HARS), Quick Inventory of Depression Symptomatology - Self Report (QIDS-SR), Clinical Global Impression (CGI).

Full Information

First Posted
January 25, 2012
Last Updated
January 27, 2012
Sponsor
Shalvata Mental Health Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01521052
Brief Title
Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for Treatment of Major Depressive Episode in the Elderly
Study Type
Interventional

2. Study Status

Record Verification Date
January 2012
Overall Recruitment Status
Unknown status
Study Start Date
January 2012 (undefined)
Primary Completion Date
December 2012 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shalvata Mental Health Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Purpose: To evaluate the safety and anti-depressive response of the H1 Coil TMS Device in elderly patients suffering from major depressive episode. Twenty-seven (27) treatment resistance depressed-patients, 68 years of age and above, currently in a depressive episode.All subjects will receive prefrontal deep rTMS of H1 Coil (42 trains of 2 seconds, 10 Hz, with 20 seconds inter-train intervals, up to 120% of motor threshold), for 4 weeks, 5 days a week, overall 20 sessions.Safety and efficacy tests will be conducted before starting the trial (screening), once a week for the trial duration and one month following end of treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
27 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
elderly depressed patients
Arm Type
Experimental
Arm Description
Twenty seven (27) patients aged 68 years or above, currently suffering from a major depressive episode, who did not respond to treatment with at least one antidepressant medications in the recommended dosage and duration, or could not tolerate at least two antidepressants.
Intervention Type
Device
Intervention Name(s)
dTMS treatment (H1 Coil)
Intervention Description
All subjects will receive prefrontal deep rTMS of H1 Coil (42 trains of 2 seconds, 10 Hz, with 20 seconds inter-train intervals, up to 120% of motor threshold), for 4 weeks, 5 days a week, overall 20 sessions.
Primary Outcome Measure Information:
Title
Safety of the H1-Coil
Description
maintaining subject's pre treatment, physical and neurological status.
Time Frame
One Month
Title
Clinical antidepressant response
Description
a decline in Hamilton depression rating scale (HDRS) from the baseline rating by 50%.
Time Frame
One Month
Secondary Outcome Measure Information:
Title
Clinical antidepressant remission
Description
exit Hamilton Depression Rating Scale <9.
Time Frame
One Month
Title
Symptomatic improvement at the end point.
Description
Change in Hamilton Anxiety Rating Scale (HARS), Quick Inventory of Depression Symptomatology - Self Report (QIDS-SR), Clinical Global Impression (CGI).
Time Frame
One Month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
68 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed by a senior psychiatrist as suffering from major depression episode according to DSM-IV (either as a part of a unipolar or a bipolar disorder). Rating on HDRS ≥ 20. Age: 68 years and above Treated for the current depressive episode, at least 6 weeks per antidepressant with one antidepressant in accepted dose, without improvement, and/or intolerance to 2 antidepressants, according to medical chart and ATHF (antidepressant treatment history form) instruction guidelines. Gave informed consent for participation in the study. Negative answers on safety screening questionnaire for TMS. If referred by a treating psychiatrist, he or she approves of the subject's participation in the study. Exclusion Criteria: Axis 2 diagnosis, which is considered prominent to the current depressive episode. Substantial suicidal risk as judged by the treating psychiatrist or by an independent psychiatrist. Attempted suicide in the past year. Cognitive impermanent - if MMSE < 24, patient will be further assessed , and may be excluded according to the primary investigator's discretion History of seizure. History of epilepsy or seizure in first degree relatives. Any CNS disorder that may increase risk of seizure significantly History of a significant head injury. History of any metal in the head (outside the mouth). Known history of any metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, surgical clips or any medical pumps. History of frequent or severe headaches. Use of hearing aids for hearing loss. Known history of cochlear implants. History of drug abuse or alcoholism. Serious and unstable medical condition, which is likely to exacerbate or endanger the patient during the treatment period. Inadequate communication with the patient. Under custodial care. Participation in current clinical study or clinical study within 30 days prior to this study. Patients suffering from bipolar disorder, not currently treated by mood stabilizers Patients declared as legally incompetent, with an appointed physical guardian and/or cannot sign informed consent due to cognitive incompetence.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dafna Shefet, MD
Phone
972-9-7478524
Email
daphnash@clalit.org.il
Facility Information:
Facility Name
Shalvata Mental Health Center
City
Hod Hasharon
Country
Israel
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dafna Shefet, MD
Phone
972-9-7478524
Email
daphnash@clalit.org.il
First Name & Middle Initial & Last Name & Degree
Dafna Shefet, MD

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for Treatment of Major Depressive Episode in the Elderly

We'll reach out to this number within 24 hrs